Professor Prasanna Sooriakumaran

Professor Sooriakumaran, MA(Oxon) BMedSci(Hons) BMBS(Hons) PGCertMedLaw ADCertClinInv(Cornell) FRCS(Urol) FEBU USMLE PhD, globally known as PS, is a consultant urological surgeon specialising in robotic surgery for prostate cancer at UCLH. He is a full/visiting Professor of Urology at the Cleveland Clinic Lerner College of Medicine, University of Oxford, and the All-India Institute of Medical Sciences Jodhpur where he is also a Visiting Professor of Robotic Surgery. PS is also a Member of the Faculty of Clinical Medicine and Member of the Congregation (sovereign body) at the University of Oxford, where he was conferred the degree of Master of Arts by resolution of the University.

PS moved to UCLH in 2017 from Oxford University having worked at Oxford University Hospitals as a high volume prostate cancer surgeon. He trained as a fellow for two years at Cornell University in New York and the Karolinska Institute in Stockholm, before his direct appointment to Oxford by the Nuffield Department of Surgical Sciences. PS is known internationally for his pioneering work in robotic surgery, especially with regards graded nerve sparing and Retzius sparing, fields in which he has published extensively.

PS is a National Clinical Impact Award regional sub-committee member, a Health Services Journal Cancer Judge, a reviewer for many grant bodies including the Rosetrees Trust, the National Institute of Health Research, and The Urology Foundation. PS has recently been awarded a National Clinical Impact Award for his impactful work in prostate cancer and robotic surgery. PS has also recently been appointed as a lead team member of the National Institute of Health and Care Excellence (NICE) specialist committee on robotic soft tissue surgery, to help develop NICE’s first ever guidelines in robotic surgery. PS also sits on the exam writers committee for the Fellowship of the Royal College of Surgeons Urology examination.

PS is a former member of the European Association of Urology (EAU) young academic group in prostate cancer, the EUA robotic urology section scientific working party, the UK National Cancer Research Institute Advanced Prostate Clinical Studies Group, and the trial management group of the STAMPEDE trial, the world’s largest interventional trial in advanced prostate cancer.

PS maintains his collaborations with urology leaders across the world.